Jonathan Chang – SVB Leerink

SVB Leerink

A SVB Leerink analyst with 15 tracked ratings across 12 distinct tickers has a 48.4% success rate on the captured sample, focusing on two sources.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

3 years ago

2023-01-10 00:00:00+00

Track record

Aggregated

48% success rate

Bullish: 9
Hold: 0
Bearish: 2

Aggregated

Not available

Bullish: 4
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
KPTI	2023-01-10	buy	$5.00	Aggregated
KPTIKARYOPHARM THERAPEUTICS INC	2023-01-10	unknown	$5.00	Aggregated
REPL	2022-12-07	buy	$34.00	Aggregated
REPLREPLIMUNE GROUP INC	2022-12-07	unknown	$34.00	Aggregated
GMAB	2022-11-10	sell	$33.00	Aggregated
GMABGENMAB - ADR	2022-11-10	unknown	$33.00	Aggregated
BCYC	2022-08-22	buy	$50.00	Aggregated
BCYCBICYCLE THERAPEUTICS PLC - ADR	2022-08-22	unknown	$50.00	Aggregated
RVMD	2022-08-10	buy	$30.00	Aggregated
RVMDREVOLUTION MEDICINES INC	2022-08-10	unknown	$30.00	Aggregated
MGNX	2022-08-09	buy	$12.00	Aggregated
MGNXMACROGENICS INC	2022-08-09	unknown	$12.00	Aggregated
MRSN	2022-08-09	sell	$14.00	Aggregated
MRSNMERSANA THERAPEUTICS INC	2022-08-09	unknown	$14.00	Aggregated
VINC	2022-06-07	buy	$6.00	Aggregated
VINCVINCERX PHARMA INC	2022-06-07	unknown	$6.00	Aggregated
IMTX	2022-06-03	buy	$26.00	Aggregated
ZLAB	2022-05-11	buy	$95.00	Aggregated
ZLABZAI LAB LIMITED - ADR	2022-05-11	unknown	$95.00	Aggregated
ADAP	2022-05-09	buy	$3.00	Aggregated
ADAPADAPTIMMUNE THERAPEUTICS PLC - ADR	2022-05-09	unknown	$3.00	Aggregated
IMTX	2022-03-24	buy	$25.00	Aggregated
KURA	2022-02-25	buy	$28.00	Aggregated
KURAKURA ONCOLOGY INC	2022-02-25	unknown	$28.00	Aggregated
IMTX	2021-07-15	buy	$27.00	Aggregated
IMTX	2021-03-17	buy	$26.00	Aggregated

Tickers covered(23)

Ticker	Ratings	Last rating	Sources
KPTI	2	2023-01-10	Aggregated
KPTIKARYOPHARM THERAPEUTICS INC	1	2023-01-10	Aggregated
REPL	2	2022-12-07	Aggregated
REPLREPLIMUNE GROUP INC	1	2022-12-07	Aggregated
GMAB	2	2022-11-10	Aggregated
GMABGENMAB - ADR	1	2022-11-10	Aggregated
BCYC	2	2022-08-22	Aggregated
BCYCBICYCLE THERAPEUTICS PLC - ADR	1

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.